Cameron McAulay, Chief Financial Officer at Transphorm, Inc. (TGAN), sold 2,806 shares at $5.67 ($16K) on 2022-11-17, disclosed to the SEC on 2022-11-21.
Open-market sale of $16k TGAN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.